| Literature DB >> 35729264 |
Constance F Wells1, Guilaine Boursier1, Kevin Yauy1,2,3, Nathalie Ruiz-Pallares1, Déborah Mechin1, Valentin Ruault1, Mylène Tharreau1, Patricia Blanchet1, Lucile Pinson1, Christine Coubes1, Marc Fila4, Julien Baleine5, Odile Pidoux5, Maliha Badr5, Christophe Milesi5, Gilles Cambonie5, Renaud Mesnage5, Maëlle Dereure6, Olivier Ardouin7, Thomas Guignard8, David Geneviève1, Mouna Barat-Houari1, Marjolaine Willems9,10,11.
Abstract
This monocentric study included fifteen children under a year old in intensive care with suspected monogenic conditions for rapid trio exome sequencing (rES) between April 2019 and April 2021. The primary outcome was the time from blood sampling to rapid exome sequencing report to parents. All results were available within 16 days and were reported to parents in or under 16 days in 13 of the 15 individuals (86%). Six individuals (40%) received a diagnosis with rES, two had a genetic condition not diagnosed by rES. Eight individuals had their care impacted by their rES results, four were discharged or died before the results. This small-scale study shows that rES can be implemented in a regional University hospital with rapid impactful diagnosis to improve care in critically ill infants.Entities:
Mesh:
Year: 2022 PMID: 35729264 PMCID: PMC9436918 DOI: 10.1038/s41431-022-01133-7
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 5.351